Patent details

EP3209647 Title: CRYSTALLINE FORMS OF 5-CHLORO-N4-[-2-(DIMETHYLPHOSPHORYL) PHENYL]-N2-{2-METHOXY-4-[4-(4-METHYLPIPERAZIN-1-YL) PIPERIDIN-1-YL]PYRIMIDINE-2,4-DIAMINE

Basic Information

Publication number:
EP3209647
PCT Application Number:
US2015056701
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP157878463
PCT Publication Number:
WO2016065028
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
CRYSTALLINE FORMS OF 5-CHLORO-N4-[-2-(DIMETHYLPHOSPHORYL) PHENYL]-N2-{2-METHOXY-4-[4-(4-METHYLPIPERAZIN-1-YL) PIPERIDIN-1-YL]PYRIMIDINE-2,4-DIAMINE
French Title of Invention:
FORMES CRISTALLINES DE 5-CHLORO-N4- [-2- (DIMÉTHYLPHOSPHORYL) PHÉNYL]-N2- {2-MÉTHOXY-4- [4- (4-MÉTHYLPIPÉRAZIN-1-YL) PIPÉRIDIN-1-YL]PYRIMIDINE-2,4-DIAMINE
German Title of Invention:
KRISTALLINE FORMEN VON 5-CHLORO-N4-[2-(DIMETNHYLPHOSPHORYL)PHENYL]-N2-(2-METHOXY-4-[4-(4-METHYLPIPERAZIN-1-YL)PIPERIDIN-A-YL]PYRIMIDIN-2,4-DIAMIN
SPC Number:

Dates

Filing date:
21/10/2015
Grant date:
03/06/2020
EP Publication Date:
30/08/2017
PCT Publication Date:
28/04/2016
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
03/06/2020
EP B1 Publication Date:
03/06/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
21/10/2035
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
24/11/2021
 
 

Name:
TAKEDA PHARMACEUTICAL COMPANY LIMITED
Address:
1-1, DOSHOMACHI 4-CHOME, CHUO-KU, OSAKA-SHI, OSAKA 541-0045, Japan (JP)

History of Owners

From:
27/05/2020
To:
24/11/2021

Name:
ARIAD Pharmaceuticals, Inc.
Address:
26 Landsdowne Street, Cambridge, MA 02139, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
19/08/2020
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
ROZAMUS, Leonard, W.
Address:
United States (US)

2

Name:
SHARMA, Pradeep
Address:
United States (US)

Priority

Priority Number:
201462066849 P
Priority Date:
21/10/2014
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/506; A61P 35/00; C07D 239/48;

Publication

Bulletin

Bulletin Heading:
CO
Bulletin edition number:
2021/13
Publication date:
02/12/2021
Description:
Section M : Transfers of property (Art. 53 of the law), change of name and/or address

European Patent Bulletin

1

Issue number:
202023
Publication date:
03/06/2020
Description:
Grant (B1)

2

Issue number:
202028
Publication date:
08/07/2020
Description:
Application number/publication number of the divisional application (Art. 76) changed

Deed

Change of owner(s)

Change Kind/ Decision Type:
Change of ownership
Deed Number:
RC20210000498A
Date Registered:
24/11/2021
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
Baker & McKenzie
Journal Edition Number:
Text:
Country Code:
Updated Licence Number:
Terminated Licence Number:

Added Owner(s)

Name:
TAKEDA PHARMACEUTICAL COMPANY LIMITED
Address:
1-1, DOSHOMACHI 4-CHOME, CHUO-KU, OSAKA-SHI, OSAKA 541-0045, Japan (JP)

Removed Pledgee

Name:
Address:

Annual Fees

Annual Fee Due Date:
31/10/2025
Annual Fee Number:
11
Annual Fee Amount:
148 Euro
Expected Payer:
Last Annual Fee Payment Date:
19/09/2024
Last Annual Fee Paid Number:
10
Last Annual Fee Paid Amount:
131 Euro
Payer:
ANAQUA SERVICES (ANC. SGA2)
Filing date Document type Number of pages
24/11/2021 Outgoing Correspondence 1
19/08/2020 Outgoing Correspondence 1
19/08/2020 Power Of Attorney 1
24/11/2021 Request For Change 7